XML 38 R32.htm IDEA: XBRL DOCUMENT v3.20.1
Summary of Significant Accounting Policies - Roll Forward of Goodwill Activity by Reportable Segment (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Goodwill [Line Items]      
Goodwill, Ending Balance $ 8,362 $ 8,362  
Operating Segments [Member]      
Goodwill [Line Items]      
Impairment     $ (19,716)
Fair value allocation 21,109    
Accumulated impairment (19,716)   (26,828)
Accumulated Goodwill 6,969   47,937
Acquisition measurement period adjustments     116
Sale of MRI assets     (394)
Goodwill, Ending Balance 8,362 8,362 8,362
Operating Segments [Member] | DermEbx And Radion [Member]      
Goodwill [Line Items]      
Acquisition cost     6,154
Operating Segments [Member] | VuComp M-Vu Breast Density Product [Member]      
Goodwill [Line Items]      
Acquisition cost     1,093
Consolidated Reporting Unit [Member] | Operating Segments [Member]      
Goodwill [Line Items]      
Fair value allocation (21,109)   (21,109)
Accumulated impairment (26,828)   (26,828)
Accumulated Goodwill 47,937   47,937
Detection [Member] | Operating Segments [Member]      
Goodwill [Line Items]      
Fair value allocation 7,663   7,663
Accumulated Goodwill 699 0  
Sale of MRI assets 0 0 (394)
Goodwill, Ending Balance 8,362 $ 8,362 8,362
Detection [Member] | Operating Segments [Member] | VuComp M-Vu Breast Density Product [Member]      
Goodwill [Line Items]      
Acquisition cost     1,093
Therapy [Member]      
Goodwill [Line Items]      
Goodwill, Ending Balance     5,700
Therapy [Member] | Operating Segments [Member]      
Goodwill [Line Items]      
Impairment     (19,716)
Fair value allocation 13,446   13,446
Accumulated impairment (19,716)    
Accumulated Goodwill $ 6,270    
Acquisition measurement period adjustments     116
Therapy [Member] | Operating Segments [Member] | DermEbx And Radion [Member]      
Goodwill [Line Items]      
Acquisition cost     $ 6,154